Eledon Pharmaceuticals, Inc. (ELDN) has 5 open-market insider trades by 3 insiders since 2021. The most active filer is David-Alexandre C. Gros, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Paul Sean Little | CFO | — | 1 | $177K | 2021-06-11 |
| David-Alexandre C. Gros | CEO | — | 3 | $58K | 2026-07-31 |
| Steven Perrin | Pres | — | 1 | $3K | 2026-07-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Steven Perrin | President | Buy | $3K | 2022-11-23 |
| David-Alexandre C. Gros | CEO | Buy | $9K | 2021-12-20 |
| David-Alexandre C. Gros | CEO | Buy | $25K | 2021-08-17 |
| Paul Sean Little | CFO | Buy | $177K | 2021-06-11 |
| David-Alexandre C. Gros | CEO | Buy | $24K | 2021-06-09 |
Companies that share insiders with ELDN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.